End points for clinical trials in acute heart failure syndromes.

Journal of the American College of Cardiology

Volumn 53, Issue 24, 2009, Pages 2248-2258

  Allen, Larry A ^a   Hernandez, Adrian F ^a   O'Connor, Christopher M ^a   Felker, G Michael ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTONIC AGENT;

ACUTE DISEASE; BIOASSAY; DISEASE COURSE; FOOD AND DRUG ADMINISTRATION; HEART FAILURE; HEMODYNAMICS; HUMAN; LENGTH OF STAY; METHODOLOGY; MORTALITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYNDROME; UNITED STATES;

ACUTE DISEASE; CARDIOTONIC AGENTS; DISEASE PROGRESSION; ENDPOINT DETERMINATION; HEART FAILURE; HEMODYNAMICS; HUMANS; LENGTH OF STAY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SYNDROME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

MLCS; MLOWN;

EID: 67649977368     PISSN: None     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.12.079     Document Type: Review

References (54)